Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 12:48 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 577–600 of 1,232 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Compliance Clear all

Conditions: Colon Cancer Screening, Colon Cancer Surveillance
Interventions: eGuide to Colonoscopy and in office ipad education; Other
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 90 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Hyperlipidemia
Interventions: Evacetrapib, Atorvastatin, Ezetimibe, Placebo; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 18 Years and older
Enrollment: 366 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 61
States / cities: Huntsville, Alabama • Mesa, Arizona • Phoenix, Arizona + 56 more

Conditions: Fatty Liver, Nonalcoholic, Liver Diseases
Interventions: Ketogenic Diet, Standard Weight Loss Diet; Other
Lead sponsor: Marc Goodman; Other
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Loneliness, Opioid Use
Interventions: Cognitive Behavior Therapy (CBT), Social Navigation Group, Controlled Group; Behavioral
Lead sponsor: University of Washington; Other
Eligibility: 18 Years and older
Enrollment: 102 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Breast Neoplasms
Interventions: Radium-223 dichloride (Xofigo, BAY88-8223), Placebo (saline), Exemestane, Everolimus; Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 283 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2022
U.S. locations: 15
States / cities: La Jolla, California • Los Angeles, California • New Haven, Connecticut + 12 more

Conditions: Sleep Apnea, Obstructive
Interventions: Telecommunications system, TLC-Control; Device · Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2008
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Asthma
Interventions: TLC-Asthma, TLC-health education; Device
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: 18 Years and older
Enrollment: 136 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2009
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Multiple Sclerosis
Interventions: Factors that influence compliance; Behavioral
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 1,040 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2005
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Obstructive Sleep Apnea
Interventions: Magnap; Device
Lead sponsor: Michael Harrison; Other
Eligibility: 21 Years to 70 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2027
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Opioid-use Disorder
Interventions: MySafeRx Inspire Plus, MySafeRx Inspire Flex; Other
Lead sponsor: University of South Florida; Other
Eligibility: 18 Years to 65 Years
Enrollment: 19 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Cancer, Breast, Cancer, Uterus, Cancer, Ovary, Obesity, Activity, Motor, Diet, Healthy
Interventions: With Love, Grandma ("Con Cariño, Abuelita"); Behavioral
Lead sponsor: University of Miami Sylvester Comprehensive Cancer Center; Other
Eligibility: 21 Years and older · Female only
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Peripheral Arterial Disease (PAD)
Interventions: Pulse Intravascular Lithotripsy (Pulse IVL); Device
Lead sponsor: Amplitude Vascular Systems, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 115 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 19
States / cities: Little Rock, Arkansas • Orange, California • Thornton, Colorado + 14 more

Conditions: Postural Orthostatic Tachycardia Syndrome
Interventions: History, Physical, blood draw, Questionnaires; Other · Behavioral
Lead sponsor: Vanderbilt University; Other
Eligibility: 13 Years to 80 Years
Enrollment: 212 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2029
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Systemic Lupus Erythematosus
Interventions: TEACH; Behavioral
Lead sponsor: Michigan State University; Other
Eligibility: 12 Years to 22 Years
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Grand Rapids, Michigan

Conditions: Whole Genome Sequencing, Acute Myeloid Leukemia, Myelodysplastic Syndromes
Interventions: ChromoSeq; Device
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 325 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2027
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Tympanic Membrane Perforation
Interventions: Eustachian tube function testing; Other
Lead sponsor: University of Pittsburgh; Other
Eligibility: 3 Years to 16 Years
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2017
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Influenza, Respiratory Tract Infections
Interventions: Enhanced texts with Callback by a Person, Enhanced Bidirectional Texts; Behavioral
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 6 Months and older
Enrollment: 246,295 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 2
States / cities: Los Angeles, California

Conditions: Adenomatous Polyps
Interventions: 0.5 mg calcitriol (1a -25-dihydroxycholecalciferol), 75 mg acetylsalicylic acid (ASA) + 1250 mg calcium carbonate (CaCO3), placebo to 0.5 mg calcitriol (1a -25-dihydroxycholecalciferol), placebo to 75 mg acetylsalicylic acid (ASA) + 1250 mg calcium carbonate (CaCO3), Colonoscopy; Drug · Procedure
Lead sponsor: Colotech A/S; Industry
Eligibility: 40 Years to 75 Years
Enrollment: 350 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 24
States / cities: Huntsville, Alabama • San Diego, California • Clearwater, Florida + 20 more

Conditions: Endometrial Neoplasms
Interventions: Time Restricted Eating (TRE) Schedule, Control Schedule; Behavioral
Lead sponsor: University of Utah; Other
Eligibility: 18 Years and older · Female only
Enrollment: 39 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Intra-abdominal Fat, Metabolic Syndrome, High Cholesterol, Triglycerides High, Diet Habit, High Blood Sugar, Liver Fat, Dietary Modification, HDL Cholesterol, Low Serum, Cardiovascular Diseases, High Density Lipoprotein Deficiency, Low-density-lipoprotein-type, Cardiovascular Risk Factor, Diabetes
Interventions: Intervention Daily Avocado; Other
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 25 Years and older
Enrollment: 1,008 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 4
States / cities: Loma Linda, California • Los Angeles, California • Boston, Massachusetts + 1 more

Conditions: Diabetes
Interventions: Adherence information, Adherence information plus motivational interviewing; Behavioral
Lead sponsor: Henry Ford Health System; Other
Eligibility: 18 Years and older
Enrollment: 1,692 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2012
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Multiple Sclerosis (MS), Fatigue, Physical Inactivity
Interventions: ExerciseRx intervention; Other
Lead sponsor: University of Washington; Other
Eligibility: 18 Years and older
Enrollment: 106 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Obstructive Sleep Apnea
Interventions: Wellth app; Behavioral
Lead sponsor: ResMed; Industry
Eligibility: 18 Years and older
Enrollment: 166 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: San Diego, California

Conditions: Ischemic Stroke
Interventions: Enhanced Stroke Education, Usual Stroke Education; Behavioral
Lead sponsor: Washington Regional Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 21 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Fayetteville, Arkansas

Search by objective public record fields.

Johns Hopkins Interactive eGuide to Colonoscopy and Ipad Office Education to Improve Colonoscopy

A Study of Evacetrapib (LY2484595) in Participants With High Cholesterol

Ketogenic Diet in Non-alcoholic Fatty Liver Disease

Decreasing Loneliness to Optimize Pain Care

Study of Radium-223 Dichloride in Combination With Exemestane and Everolimus Versus Placebo in Combination With Exemestane and Everolimus in Subjects With Bone Predominant HER2 Negative Hormone Receptor Positive Metastatic Breast Cancer

Telecommunications System in Sleep Apnea

Telecommunications System in Asthma

Factors That Influence Compliance With Disease-Modifying Therapy in Multiple Sclerosis

Magnetic Apnea Prevention(MAGNAP) Device to Treat Obstructive Sleep Apnea:First-In-Human Study of Feasibility and Safety

Evaluating Adaptive Dispenser Initiation Protocols for MySafeRx During Post-detox Buprenorphine Treatment- a Pilot Study

With Love, Grandma ("Con Cariño, Abuelita") Pilot Study

Amplitude Vascular Systems (AVS) Lithotripsy POWER PAD 2 Trial

Assessment of Antibodies and Inflammatory Markers in Postural Tachycardia Syndrome

Telehealth CBT for Adolescents and Young Adults With Childhood-onset Systemic Lupus Erythematosus

Whole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profiling in AML and MDS

Eustachian Tube Function and Myringoplasty/Tympanoplasty

Patient Portal Flu Vaccine Reminders_RCT 5 (LADHS)

Chemoprevention of Colorectal Adenomas

Time Restricted Eating (TRE) Among Native Hawaiian/Pacific Islander Women at Risk for Endometrial Cancer

Habitual Diet and Avocado Trial

Multi-arm Intervention Diabetes Adherence Study

Increasing Physical Activity for Adults With Multiple Sclerosis (MS)

Evaluation of an Incentive-based Intervention to Improve 90-day Adherence in PAP-Naive Patients

REcurrent Stroke Prevention Through Personalized Education by Clinical Trainers (RESPPECT Trial)